INLOG acquired by GENII SOFTWARE GROUP
Context
Private equity firm Abenex, alongside the management team, has successfully completed the divestiture of healthcare software publisher Inlog to Munich-based GENII Software Group. Orchestrated by investment bank Lincoln International, the transaction marks the exit of Abenex following a successful transformation period. The acquirer, GENII Software Group, is majority-backed by private equity sponsor Bregal Unternehmerkapital, with additional support from Elvaston. For the acquirer GENII Software Group, the buyout significantly strengthens its Laboratories division and consolidates its position as a leading European provider of specialized enterprise software. During Abenex's ownership tenure, Inlog doubled its revenues, completed three strategic acquisitions, and expanded its footprint into Germany and the Benelux region. Partnering with GENII will provide Inlog with the necessary scale and resources to accelerate international revenue growth and drive product innovation, particularly focusing on AI and cloud-based technologies.
It is worth noting that the fund Abenex took control of Inlog through an LBO in 2020.
INLOG, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the TMT (Tech, Media, Telecom) sector (14.8x).
Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.
-> Deep-dive in TMT (Tech, Media, Telecom) market trends
Target
Inlog is a software editor for the healthcare sector, specializing in blood product traceability and laboratory management. Founded after its spin-off from the American Haemonetics Corporation, Inlog has structured its teams and now has 80 employees worldwide. The company opened a subsidiary in Germany in 2022 and generates nearly 20% of its revenue internationally. Inlog offers innovative solutions for healthcare systems and has made several acquisitions, including the French companies Ubilab and Viskali, as well as the Belgian company Moonchase.
Ent. Value
LOGIN
Equity Value
LOGIN
Multiples
EV / Revenue
LOGIN
EV / EBITDA
LOGIN
EV / EBIT
LOGIN
Historical Financials (EUR)
Other operations with INLOG
| Date | Acquirer | Target | Country | Sector | Deal Context |
|---|---|---|---|---|---|
| 09/2020 | ABENEX | INLOG | FRANCE | Software | Private equity firm Abenex, utilizing its dedicated Small Caps fund Abenex Croissance, has successfully completed the acquisition of healthcare software publisher Inlog from US-based industrial group Haemonetics |
REFERENCES
Valuation range: EV 50M - 150M EUR
Revenue range: 5M - 25M EUR
EBITDA range: 5M - 25M EUR
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INLOG by GENII SOFTWARE GROUP are reserved for mynth community members. Register for free to unlock full data.
Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).
Target: inlog
Acquirer: genii software group